SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-253339
Filing Date
2014-06-27
Accepted
2014-06-27 16:18:55
Documents
7
Period of Report
2014-06-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d751447d8k.htm 8-K 24328
2 EX-1.1 d751447dex11.htm EX-1.1 377673
3 EX-4.1 d751447dex41.htm EX-4.1 69804
4 EX-4.2 d751447dex42.htm EX-4.2 67451
5 EX-4.3 d751447dex43.htm EX-4.3 69771
6 EX-5.1 d751447dex51.htm EX-5.1 20045
7 EX-99.1 d751447dex991.htm EX-99.1 6394
  Complete submission text file 0001193125-14-253339.txt   636706
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 14946198
SIC: 2835 In Vitro & In Vivo Diagnostic Substances